Adverse Events: Elevidys (Delandistrogene Moxeparvovec)
Adverse Events: Elevidys (Delandistrogene Moxeparvovec)
The FDA FOIA Database for Regulatory Professionals
Search 63,000+ FDA FOIA requests — closed records, pending requests, and release histories — in one place. Know what's already been filed, who filed it, and what came back.
- Full request subjects and descriptions
- Requester names and organizations
- Control numbers for tracking and reference
- Close dates, processing times, and outcomes
- Pending and open requests filed 2020–2026
- Advanced search across document type, industry, and year
One custom request costs $149. A subscription costs the same — and covers everything.
Monthly and annual plans available. Cancel anytime.
This product provides a detailed summary of adverse events related to the use of Elevidys (Delandistrogene Moxeparvovec), based on reports submitted to the FDA Adverse Event Reporting System (FAERS). The data highlights incidents linked to this drug, offering insights into potential safety concerns.
Please note that the dataset includes only adverse events recorded in FAERS and may contain duplicate reports, where multiple entries could refer to the same event. This comprehensive report is useful for monitoring drug safety and assessing potential risks associated with Elevidys.
Couldn't load pickup availability